A phase II study of oral ENMD-2076 administered to patients (pts) with advanced soft tissue sarcoma (STS).
暂无分享,去创建一个
H. Mackay | A. Oza | M. Moore | M. Blackstein | N. Dhani | A. Razak | D. Hogg | Abha A. Gupta | H. Loong
暂无分享,去创建一个
H. Mackay | A. Oza | M. Moore | M. Blackstein | N. Dhani | A. Razak | D. Hogg | Abha A. Gupta | H. Loong